Letter to the Editor
HLA variants and inhibitor development in hemophilia A: results from the HEMFIL study group
Márcio Antônio Portugal Santanaa,b, Daniel Gonçalves Chavesa, Felipe CB Souzaa, Suely Meireles Rezendeb,
Autor para correspondência
suely.rezende@uol.com.br
Corresponding author at: Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Avenida Alfredo Balena, 190 2nd floor, room 255, Belo Horizonte, MG CEP: 30130-100, Brazil.
Corresponding author at: Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Avenida Alfredo Balena, 190 2nd floor, room 255, Belo Horizonte, MG CEP: 30130-100, Brazil.
Lido
2444
Vezesque se leu este artigo
542
Total PDF
1902
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 12 | 153 | 95 | 248 |
| 2025 11 | 254 | 69 | 323 |
| 2025 10 | 186 | 46 | 232 |
| 2025 9 | 168 | 31 | 199 |
| 2025 8 | 118 | 33 | 151 |
| 2025 7 | 116 | 33 | 149 |
| 2025 6 | 93 | 15 | 108 |
| 2025 5 | 98 | 17 | 115 |
| 2025 4 | 67 | 17 | 84 |
| 2025 3 | 69 | 16 | 85 |
| 2025 2 | 49 | 23 | 72 |
| 2025 1 | 55 | 25 | 80 |
| 2024 12 | 81 | 32 | 113 |
| 2024 11 | 85 | 36 | 121 |
| 2024 10 | 281 | 23 | 304 |
| 2024 9 | 29 | 31 | 60 |
Mostrar tudo
